Publication | Closed Access
Synthesis and In Vitro Anti‐Tumor, Anti‐Mycobacterial and Anti‐HIV Activities of Diethylene‐Glycol‐Tethered Bis‐Isatin Derivatives
61
Citations
29
References
2018
Year
Diethylene GlycolChemoprevention StrategyImmunotherapeuticsPharmaceutical ChemistryTumor BiologyVitro Anti‐tumorMedicinal ChemistryDiethylene‐glycol‐tethered Bis‐isatin DerivativesAntiviral Drug DevelopmentTumor ImmunityAnti-cancer AgentRadiation OncologyTubulin InhibitionTumor TargetingPharmacologyAntiviral CompoundBiomolecular EngineeringDrug TargetingAnti‐hiv ActivitiesNatural SciencesMedicineBis‐isatin DerivativesSmall MoleculesDrug Discovery
Abstract A series of diethylene glycol tethered bis‐istain derivatives 4 a‐o were designed, synthesized and screened for their biological activities in this paper. Eight bis‐isatin derivatives displayed broad‐spectrum activities against all tested drug‐sensitive and drug‐resistant cancer cells with IC 50 in a range of 8.32 to 49.73 μ M. The most active derivative 4 d was >2.5 folds more potent than etoposide against Hela, HCT‐116, A549 and drug‐resistant MCF‐7/DOX (Doxorubicin‐resistant MCF‐7) cells and was comparable to etoposide against DU145, SKOV3 and MCF‐7. Tubulin inhibitory results suggested that this kind of bis‐istain derivatives could exert their anti‐cancer activities through tubulin inhibition. The eight bis‐isatin derivatives with high anti‐tumor activity were selected for further screen to investigate their anti‐mycobacterial and anti‐HIV activities, but the majority of them only exhibited weak to moderate activities.
| Year | Citations | |
|---|---|---|
Page 1
Page 1